Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized
Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips
Gero LLC Attends the Bio International Convention 2016
Gero LLC, a leading drug development company, arranged a session at the Bio International Convention 2016 held at San Francisco from 6th-9th June. This event was first of its kind, since it focused on touching upon crucial topics such as combating the aging process, on a higher level. This yearly... - December 15, 2016 - PR Point
Bioscience Americas Lauds Passage of the 21st Century Cures Act
President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas
The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016 - The Cardiac & Vascular Institute
Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies
Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum
New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs
New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC
MedLogiq Brings Acclaimed VAT® to Medical Devices
Proven solutions make medical devices safer, more reliable and improves time-to-market. Powerful technology solutions will be integrated with the General Infusion Pump (GIP) to assist in standardizing performance measurement, event monitoring and reporting. - November 30, 2016 - MedLogiq
Digital Health Startup Vitalistics Announces Public Launch
Vitalistics, a digital health startup transforming the overnight pulse oximetry and home sleep testing experience, launches today. - November 30, 2016 - Vitalistics
Telehealth Virtual Visits Market in US – Strategic Assessment and Forecast Till 2021
Analysts at Beige Market Intelligence predicts that the telehealth virtual visits market in US is expected to cross US$800 million in 2021 growing at a CAGR closed to 18%. - November 26, 2016 - Beige Market Intelligence
Partnering for Cures: Highlights from The Chauncey F. Lufkin III Foundation’s Participation at the Milken Institute’s FasterCures 2016 Partnering for Cures
The Chauncey F. Lufkin III Foundation was proud to participate in the Milken Institute’s annual Partnering for Cures Conference at The Grand Hyatt New York, held November 3-18, 2016. Partnering for Cures connects hundreds of decision-makers from across the medical research system who are... - November 23, 2016 - The Chauncey F. Lufkin III Foundation
Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy
The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore
Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research
Transnetyx, an automated genotyping company, today announced that it will reach 12 million samples processed by the end of 2016. Since it began its operations in 2004, Transnetyx has served the research of more than 600 organizations – universities, hospitals and bioscience companies –... - November 16, 2016 - Transnetyx
New Gastrointestinal Pathogen Assays Available from ALPCO
ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO
New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO
Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
Gastric Cancer Foundation Event Promotes Research Funding to Improve Treatments and Save Lives - "A Cause for Hope" on November 18 in the San Francisco Bay Area
Stomach Cancer is the third leading cause of cancer deaths in the world, and is increasingly affecting young people. Yet only a tiny fraction of the nearly 1M gastric cancer sufferers worldwide have well-defined tumor mutations that can be addressed with current treatment options. To increase funding for the disease and encourage more researchers to focus on stomach cancer treatment, the Gastric Cancer Foundation will hold its Annual Event, A Cause for Hope, November 18 in the SF Bay Area. - October 17, 2016 - Gastric Cancer Foundation
Retinal Consultants of Arizona Opens Largest, Most Advanced Clinical, Surgical & Retina Research Institute in Phoenix
Retinal Consultants of Arizona (RCA) – one of the nation’s leading Retina & Vitreous clinical research and patient treatment facilities – announces the opening of a 35,000 sq. foot clinical, surgical and research facility to continue addressing the growing number of Arizonans dealing with retina related disease such as age-related macular degeneration and diabetic eye disease – both are leading causes of blindness nationally. - October 13, 2016 - Retinal Consultants of Arizona
Oxford AHSN Recognizes the SGC with Its Annual Public-Private Collaboration Award
Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award. - October 11, 2016 - The SGC
Diabetic Gastroparesis Treatment Market Worth US$ 3,769.3 Mn by 2024: PMR Research
This Persistence Market Research (PMR) report examines the global diabetic gastroparesis treatment market and identifies trends likely to govern the market during the period 2016–2024. - September 29, 2016 - Persistence Market Research
STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products
Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN
Spaulding Clinical Research Named “Best Phase I Drug Development CRO”
International Life Sciences continue to have a global impact and be captivated by daily breakthroughs that focus on companies, departments, and individuals who truly deserve to be identified as unique in their industry. As such, Spaulding Clinical Research keeps conducting tests and research, embracing the most advanced technology to forge ahead into clinical research and biometric solutions. - September 24, 2016 - Spaulding Clinical Research, LLC
EpiPen® Insurance Cover Launched Via EpiPenIns
Following the recent uproar about Mylan, licensed manufacturer of EpiPen® products, a consortium of Lloyd's names and reinsurance professionals have decided to offer a cost effective option to replace a used EpiPen®. Via the website EpiPenIns, a replacement service (or financial... - September 23, 2016 - EpiPenIns
ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader
ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO
Rainforest Educator, John Easterling, Kicks Off 6th Annual Association of Natural Health Conference in Douglasville, Ga on October 13 (Full Conference October 13-15)
Achieving Balance and Restoring Health. The Association of Natural Health will be presenting dynamic natural health leaders October 13 - 15 at the Douglasville Conference Center, 6700 Church Street, Douglasville, GA October 13 - 15, 2016. Keynote presentations include: Rainforest Botanicals for Radiant Health, Healing the Gut, Mastering Metabolic Chaos, Methylation's Role in Neurological Health, Neurotransmitters: The Foundation of Our Biochemistry, Art is a Path to Wellness. - August 26, 2016 - Association of Natural Health
Cofactor of BRCA1: A Promising Genetic Marker for Common Malignant Liver Cancer Therapy, According to PiscoMed's Oncology Journal AMOR
Researchers found strong indication of COBRA1’s involvement in the growth and metastasis of hepatocellular carcinoma. - August 26, 2016 - PiscoMed Publishing Pte Ltd
Clinical Trial Supplies
Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged... - August 25, 2016 - Business Dialogue
PlantVax Contracted for Key Enzyme Production in Chemical Warfare Disclosure Sprays
PlantVax, Inc. has been contracted by a tier one US defense contractor as the primary supplier of Recombinant Human Acetylcholinesterase (AChE) in support of a Program of Record chemical warfare disclosure spray. The disclosure spray is a first-of-its-kind plant derived enzyme-based sensor that... - August 23, 2016 - Huckworthy LLC
ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes
ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO
Robert W. McIntosh, Ph.D. Honored as a Professional of the Year by Strathmore's Who's Who Worldwide Publication
Robert W. McIntosh, Ph.D. of Pearl City, Hawaii has been honored as a Professional of the Year for 2016 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the fields of research and development in basic neurosciences and governmental consulting in... - August 16, 2016 - Strathmore Worldwide
HealthAxis Group, USF Partners on Parkinson’s Research Project
Researchers will be able to study whether a group of commonly used drugs affect the onset of Parkinson’s disease, thanks to a new grant partnership between the University of South Florida and HealthAxis Group. - August 16, 2016 - HealthAxis Group
Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality
The Medical Technology and Practice Patterns Institute, Inc. (MTPPI) announces that it has been awarded an R01 research grant by the Agency for Healthcare Research and Quality (AHRQ). The grant will be used to investigate the impact of the End-Stage Renal Disease Prospective Payment System (ESRD PPS) reform that was enacted by Congress in 2011. - August 11, 2016 - Medical Technology and Practice Patterns Institute
Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge
Despite slowing Chinese pharma market growth to 7.6% in 2015, it remains a high growth spot with numerous emerging opportunity areas, according to the China Pharmaceutical Guide 2016 (11th Edition). Hot off the press, the China Pharmaceutical Guide 2016, an indispensable reference for MNC executives with China responsibilities for over a decade, aims to help proactive HQ and local executives feel the pulse of Chinese healthcare and stay in the driver seat of their business in the country. - August 09, 2016 - WiCON International Group LLC
Baebies to Exhibit and Display FINDER Prototype at 2016 AACC Annual Scientific Meeting
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that the company will exhibit and display a prototype of FINDERTM at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo. FINDER, currently under development, is a small, innovative and... - July 28, 2016 - Baebies, Inc.
Bioscience Americas Outlines Growth Strategy
Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas
Reilly H. Stewart Honored with the Lifetime Achievement Award by Strathmore's Who's Who Worldwide Publication
Reilly H. Stewart of Indio, California has been honored with the Lifetime Achievement Award by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of healthcare. This award is presented to those individuals who have made a difference in the... - July 19, 2016 - Strathmore Worldwide
Academy Medical Partnership with Acelity Strengthens Regenerative Medicine Offering to Federally Funded Medical Facilities
Service-Disabled Veteran-Owned Small Business, Academy Medical, has forged a partnership with Acelity, a globally diversified wound care and regenerative medicine company, to distribute the company’s full line of regenerative medicine products including ALLODERM™ Regenerative Tissue Matrix and STRATTICE™ Reconstructive Tissue Matrix within the Department of Veterans Affairs (VA) and Indian Health Services (IHS) centers. - July 12, 2016 - Academy Medical
Patricia A. Cleary Honored as a VIP for Two Consecutive Years by Strathmore's Who's Who Worldwide Publication
Patricia A. Cleary of Arlington, Virginia has been honored as a VIP for two consecutive years, 2015 and 2016, by Strathmore’s Who’s Who Worldwide Edition for her outstanding achievements and success in the field of education. About Patricia A. Cleary Ms. Cleary has 50 years experience... - July 09, 2016 - Strathmore Worldwide
Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology
New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics products, announced today that it has entered into an exclusive joint collaboration and license agreement with MO-SCI Corporation of Rolla, Missouri for an exciting new... - June 30, 2016 - Prosidyan, Inc.
TrialX Launches Trialspace at DIA 2016 – An Easy to Use Clinical Trials Website Builder with Built-in Recruitment Tracking Tools to Launch Your Study Website in Minutes
TrialX announces the launch of Trialspace, a clinical trial website builder (http://trialx.com/trialspace) for sponsors, CROs, patient recruitment agencies and investigators. Trialspace comes with a sophisticated patient referral and recruitment tracking engine that is easy to use and provides a... - June 24, 2016 - Applied Informatics
Leading Scientists on Neuroplasticity Present at Brain IDEAS Symposium, Aug. 5th
Invisible Disabilities Association is hosting their 2nd Annual Brain IDEAS Symposium on Aug. 5th in Denver, CO focusing on Brain Disorders, Brain Health, and Brain Therapy. 9 expert presenters will each deliver dynamic, science and story-filled talks on topics including Neuroplasticity, ADHD, ADD, Autism, Learning Disabilities, Dyslexia, Alzheimer’s, Nutrition, Microbiome, Mental Training, Therapeutic Humor, Stroke, PTSD, EMDR and TBI followed by 3 Expert Led Panels for questions and answers. - June 17, 2016 - Invisible Disabilities Association
Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant
Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN
US Researchers Call for Re-Evaluation of Microbial Testing of Cannabis Following New, Sequencing-Based Study
A new US study suggests that some of the medicinal benefits of dispensary grade Cannabis could be compromised because the flowers host potentially harmful yeasts and toxic molds, which cannot be detected by industry standard culturing techniques. The report, ‘Cannabis microbiome sequencing... - June 16, 2016 - Faculty of 1000
NanoHybrids to Sponsor Gold Nanoparticles for Selected Research Proposals
For a limited time, NanoHybrids is accepting applications for a chance to win a supply of their top Gold Nanoparticles to enhance imaging project results. - June 10, 2016 - NanoHybrids
ALPCO Releases New Broad Range Periostin ELISA
ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016 - ALPCO
TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk
In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of... - May 17, 2016 - TriFoil Imaging
Doctors Use Bitcoin Tech to Improve Transparency in Clinical Trial Research
Two clinicians have devised a new system to prevent clinical trial documents being secretly altered to make new medications look more effective than they are. The new method aims to solve this problem using blockchains, the technology that underpins the virtual currency Bitcoin. - May 13, 2016 - Faculty of 1000
Dare to Rise - Reshaping Humanity by Reshaping Yourself
A brand new book by Maria Teresa De Donato Ph.D and Denis Gorce-Bourge. Dare to Rise is written for the many people who feel a calling for more “awareness in living,” who are looking to grow more consciously and find clear understanding of the mechanics of responsibility in action. - May 03, 2016 - GB Life Coaching Ltd
ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
Fahad Al Tamimi to Host a Special Dinner in Support of Research Into Radiation Therapy
Fahad Al Tamimi will welcome high profile guests in London next week to support further research into the area of radiation therapy. - April 22, 2016 - Fahad Al Tamimi Philanthropy